Publications
Google Scholar profile | PubMed Bibliography | UCSF Profile
Gontrum EQ, Paolillo EW, Lee S, Diaz V, Ehrenberg AJ, Saloner R, Mundada NS, La Joie R, Rabinovici G, Kramer JH, Casaletto K. Neuropsychiatric profiles and cerebral amyloid burden in adults without dementia. Dementia and Geriatric Cognitive Disorders. 2024. PMID: 38513620.
Karvelas N, Oh B, Wang E, Cobigo Y, Tsuei T, Fitzsimons S, Younes K, Ehrenberg AJ, Geschwind MD, Schwartz D, Kramer JH, Ferguson AR, Miller BL, Silbert LC, Rosen HJ, Elahi FM. Enlarged perivascular spaces are associated with white matter injury, cognition and inflammation in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Communications. 2024. PMID: 38495305.
Walker JM, Orr ME, Orr TC, Thorn E, Christie T, Yokoda RT, Vij M, Ehrenberg AJ, Marx GA, McKenzie AT, Kauffman J, Selmanovic E, Wisniewski T, Drummond ES, White CL, Crary JF, Farrell K, Kautz TF, Daoud EV, Richardson TE. Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer disease and primary age-related tauopathy. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2023. PMID: 37777848.
Ehrenberg AJ, Kelberman MA, Liu KY, Dahl MJ, Weinshenker D, Falgàs N, Dutt S, Mather M, Ludwig M, Betts MJ, Winer JR, Teipel S, Weigand AJ, Eschenko O, Hämmerer D, Leiman M, Counts SE, Shine JM, Robertson IH, Levey AI, Lancini E, Son G, Schneider C, Egroo MV, Liguori C, Wang Q, Vazey EM, Rodriguez-Porcel F, Haag L, Bondi MW, Vanneste S, Freeze WM, Yi YJ, Maldinov M, Gatchel J, Satpati A, Babiloni C, Kremen WS, Howard R, Jacobs HIL, Grinberg LT. Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 19(5), 2182–2196. 2023. PMID: 36642985.
Theofilas P, Piergies AMH, Li SH, Petersen C, Ehrenberg AJ, Eser RA, Chin B, Yang T, Khan S, Ng R, Spina S, Seeley WW, Miller BL, Arkin MR, Grinberg LT. [Pre-print] Caspase-6-cleaved tau is relevant in Alzheimer’s disease but not in 4-repeat tauopathies: diagnostic and therapeutic implications. Neuropathology and Applied Neurobiology. e12819. 2022. PMID: 35508761.
Mattsson-Carlgren N, Grinberg LT, Boxer A, Ossenkoppele R, Jonsson M, Seeley W, Ehrenberg AJ, Spina S, Janelidze S, Rojas-Martinez J, Rosen H, La Joie R, Lesman-Segev O, Iaccarino L, Kollmorgen G, Ljubenkov P, Eichenlaub U, Gorno-Tempini ML, Miller B, Hansson O, and Rabinovici GD. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration. Neurology. 98(11): e1137-e1150. 2022. PMID: 35173015.
Brook CE, Northrup GR, Ehrenberg AJ, the IGI Testing Consortium, Doudna JA, Boots M. Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment. Epidemics. 37: 100527. 2021. PMID: 34814094. PubMed
Stahl EC, Gopez AR, Tsuchida CA, Fan VB, Moehle EA, Witkowsky LB, Hamilton JR, Lin-Shiao E, McElroy M, McDevitt SL, Ciling A, Tsui CK, Pestal K, Gildea HK, Keller A, Sylvain IA, Williams C, Hirsh A, Ehrenberg AJ, Kantor R, Metzger M, Nelson KL, Urnov FD, Ringeisen BR, Giannikopoulos P, Doudna JA. IGI Testing Consortium. LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples. PLoS One. 16(11): e0258263. 2021. PMID: 34758033. PubMed
Hamilton JR, Stahl EC, Tsuchida CA, Lin-Shiao E, Tsui CK, Pestal K, Gildea HK, Witkowsky LB, Moehle EA, McDevitt SL, McElroy M, Keller A, Sylvain I, Hirsh A, Ciling A, Ehrenberg AJ, IGI SARS-CoV-2 consortium, Ringeisen BR, Huberty G, Urnov FD, Giannikopoulos P, Doudna JA. Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples. PLoS One. 16(8): e0255690. 2021. PMID: 34351984. PubMed
Ehrenberg AJ, Moehle EA, Brook CE, Doudna Cate AH, Witkowsky LB, Sachdeva R, Hirsh A, Barry K, Hamilton JR, Lin-Shiao E, McDevitt S, Valentin-Alvarado L, Letourneau KN, Hunter L, Keller A, Pestal K, Frankino PA, Murley A, Nandakumar D, Stahl EC, Tsuchida CA, Gildea HK, Murdock AG, Hochstrasser ML, O'Brien E, Ciling A, Tsitsiklis A, Worden K, Dugast-Darzacq C, Hays SG, Barber CC, McGarrigle R, Lam EK, Ensminger DC, Bardet L, Sherry C, Harte A, Nicolette G, Giannikopoulos P, Hockemeyer D, Petersen M, Urnov FD, Ringeisen BR, Boots M, Doudna JA; IGI SARS-CoV-2 Testing Consortium. Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus. PLoS One. 2021. PMID: 34038425. PubMed
Ehrenberg AJ, Leng K, Letourneau KN, Hernandez I, Lew C, Seeley WW, Spina S, Miller BL, Heinsen H, Kampmann M, Kosik KS, Grinberg LT. Patterns of neuronal Rhes as a novel hallmark of tauopathies. Acta Neuropathologica. 2021. PMID: 33677647. PubMed
Leng K, Li E, Eser R, Piergies A, Sit R, Tan M, Neff N, Li SH, Rodriguez RD, Suemoto CK, Leite REP, Ehrenberg AJ, Pasqualucci CA, Seeley WW, Spina S, Heinsen H, Grinberg LT, Kampmann M. Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease. Nature Neuroscience. 24(2): 276-287. 2021. PMID: 33432193. PubMed
Llibre-Guerra JJ, Lee SE, Suemoto CK, Ehrenberg AJ, Kovacs GG, Karydas A, Staffaroni A, Resende EDPF, Kim EJ, Hwang JH, Ramos EM, Wojta KJ, Pasquini L, Pang SYYP, Spina S, Allen IE, Kramer J, Miller BL, Seeley WW, Grinberg LT. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP. Brain Pathology. e12924. 2020. PMID: 33314436. PubMed
IGI SARS-CoV-2 Testing Consortium [including Ehrenberg AJ]. Blueprint for a pop-up SARS-CoV-2 testing lab. Nature Biotechnology. 38(7): 791-797. 2020. PMID: 32555529. PubMed
Ehrenberg AJ, Khatun A, Coomans E, Betts M, Capraro F, Thijssen E, Senkevich K, Bharucha T, Schott JM, Pereira J, Mattsson N, Grinberg LT, Jagust W, Lashley T, Carter SF, Ashton N, Hanrieder J, Zetterberg H, Schöll M, Paterson RW. Relevance of Biomarkers Across Different Neurodegenerative Diseases. Alzheimer’s Research and Therapy. 12(56). 2020. PMID: 32404143. PubMed
Ehrenberg AJ, Morales DO, Piergies AMH, Li SH, Tejedor JS, Mladinov M, Mulder J, Grinberg LT. A manual multiplex immunofluorescence method for investigating neurodegenerative diseases. Journal of Neuroscience Methods. 39: 108708. 2020. PMID: 32243897. PubMed
Resende EDPF, Nolan AL, Petersen C, Ehrenberg AJ, Miller Z, Spina S, Miller BL, Seeley WW, Rosen HJ, Grinberg LT. Language & spatial dysfunction in Alzheimer’s disease with white matter thorn shaped astrocytes. Neurology. 94(13): e1353-e1364. 2020. PMID: 32001514. PubMed
Oh J, Eser RA, Ehrenberg AJ, Morales D, Petersen C, Kudlacek J, Dunlop SR, Theofilas P, Resende EDPF, Cosme C, Alho EJL, Spina S, Walsh CM, Miller BL, Seeley WW, Bittencourt JC, Neylan TC, Heinsen H, Grinberg LT. Profound degeneration of wake-promoting neurons in Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 15(10): 1253–1263. 2019. PMID: 31416793. PubMed
Petersen C, Nolan AL, de Paula França Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML, Rosen HJ, Kramer JH, Spina S, Rabinovici GD, Miller BL, Seeley WW, Heinsen H, Grinberg LT. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathologica. 138(4): 597–612. 2019. PMID: 31250152. PubMed
Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 142(9): 2558–2571. 2019. PMID: 31327002. PubMed
Betts M, Ehrenberg AJ, Hämmerer D, Duzel E. Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. Frontiers in Neuroscience. 12:401. 2018. PMID: 29928191. PubMed
Ehrenberg AJ, Suemoto CK, Resende EDPF, Petersen C, Leite REP, Rodriguez RD, Ferretti-Rebustini REL, You M, Oh J, Nitrini R, Pasqualucci CA, Jacob-Filho W, Kramer J, Gatchel J, Grinberg LT. Neuropathologic correlates of psychiatric symptoms in Alzheimer’s disease. Journal of Alzheimer’s Disease. 66(1): 115-126. 2018. PMID: 30223398. PubMed
Eser RA, Ehrenberg AJ, Petersen C, Dunlop S, Mejia MB, Suemoto CK, Walsh CM, Rajana H, Oh J, Theofilas P, Seeley WW, Miller BL, Neylan TC, Heinsen H, Grinberg LT. Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. Journal of Neuropathology and Experimental Neurology. 77(2): 149-161. 2018. PMID: 29304218. PubMed
Theofilas P, Ehrenberg AJ, Nguy A, Thackrey JM, Dunlop S, Mejia MB, Alho AT, Leite REP, Rodriguez RD, Suemoto CK, Nascimento CF, Chin M, Medina-Cleghorn D, Cuervo AM, Arkin M, Seeley WW, Miller BL, Nitrini R, Pasqualucci CA, Filho WJ, Rueb U, Neuhaus J, Heinsen H, Grinberg LT. Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiology of Aging. 61: 1-12. 2018. PMID: 29031088. PubMed
Ehrenberg AJ, Nguy AK, Theofilas P, Dunlop S, Suemoto CK, Alho AT, Leite RP, Rodriguez RD, Mejia MB, Rüb U, Farfel JM, Ferretti-Rebustini REL, Nascimento CF, Nitrini R, Pasquallucci CA, Jacob-Filho W, Miller B, Seeley WW, Heinsen H, Grinberg LT. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's Disease. Neuropathology and Applied Neurobiology. 43(5): 393-408. 2017. PMID: 28117917. PubMed
Theofilas P, Ehrenberg AJ, Dunlop S, Di Lorenzo Alho AT, Nguy A, Leite REP, Rodriguez RD, Mejia MB, Suemoto CK, Ferretti-Rebustini REL, Polichiso L, Nascimento CF, Seeley WW, Nitrini R, Pasqualucci CA, Filho WJ, Rueb U, Neuhaus J, Heinsen H, Grinberg LT. Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 13(3): 236-246. 2017. PMID: 27513978. PubMed
Non-peer reviewed
The Editors of Alzheimer’s and Dementia. New Thinking About Thinking, Part 3. Advice on preparing a successful manuscript for Alzheimer's & Dementia. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 16(7): 949-952. 2020. PubMed
The Editors of Alzheimer’s and Dementia. Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 16(4): 587-588. 2020. PMID: 32202041. PubMed
Academic positions
Scientific Lead, Interventional Genomics Unit | 2022-Present
Innovative Genomics Institute, University of California, Berkeley
Principal Investigators: Jennifer Doudna, PhD and Petros Giannikopoulos, MD
Graduate Student Researcher | 2019-Present
Helen Wills Neuroscience Institute, University of California, Berkeley
Molecular pathology of blood-brain barrier dysfunction, stress neurobiology, and age-related neurodegeneration
Principal Investigator: Daniela Kaufer, PhD
Clinical Liaison and Regulatory Analyst | 2020-2021
Innovative Genomics Institute, University of California, Berkeley
Creation and management of a new CLIA-certified clinical lab for SARS-CoV-2 testing
Principal Investigators: Jennifer Doudna, PhD and Fyodor Urnov, PhD
Research Associate | 2013-Present
Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco
Neuropathologic foundations of the early stages of neurodegenerative diseases
Principal Investigator: Lea T. Grinberg, MD, PhD
Research and Field Assistant | 2015-2019
Department of Integrative Biology, University of California, Berkeley
Comparative neurology and neuroethology in Carnivoran wetland ecotone specialists
Principal Investigator: Alan B. Shabel, PhD
Research Intern | 2012-2013
Multiple Sclerosis Genetics Research Lab, Department of Neurology, University of California, San Francisco
Design of iPSC tissue banks by assessment of HLA haplotype compatibility
Principal Investigator: Pierre-Antoine Gourraud, MPH, PhD
Education
Ph.D. | 2019-Present
Dept. of Integrative Biology, University of California, Berkeley, Berkeley, CA.
Dissertation Committee: Daniela Kaufer, Ph.D. (Chair); Lea Grinberg, M.D., Ph.D.; José Pablo Vázquez-Medina, Ph.D.; William Jagust, M.D.; Fyodor Urnov, Ph.D.
Thesis: A Locus to study selective vulnerability in stress and neurodegeneration
B.A. | 2013-2017
Integrative Biology (Ecology, Evolution, and Organismal Biology) and Molecular and Cellular Biology (Developmental Genetics)
University of California, Berkeley, Berkeley, CA.
Certificate programs, training, and other coursework
Certificate in Teaching and Learning in Higher Education | 2019-2022
University of California, Berkeley, Berkeley, CA
Immersion Course in Drug Discovery, Drug Development, and Regulation | 2023
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
Teaching
Graduate Student Instructor, Integrative Biology 77B, Integrative Human Biology, Spring 2023
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA
Instructor and course coordinator. 130 students, Instructor of Record: Tyrone Hayes, PhD
Graduate Student Instructor, Integrative Biology 139, Neurobiology of Stress, Fall 2022
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA
Discussion section leader. 60 students, Instructor of Record: Daniela Kaufer, PhD
Graduate Student Instructor, Integrative Biology 169, Evolutionary Medicine, Spring 2019
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA
Discussion section leader. 85 students, Instructor of Record: Thomas Carlson, MD
Head Facilitator and Instructor, Integrative Biology 198, Neurozoology: Animal Brains and the Environment, Spring 2017
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA
Curriculum development, lecturer and field leader. 82 students, Faculty Adviser: Alan Shabel, PhD
Head Facilitator and Instructor, Integrative Biology 98/19, Neurozoology: Animal Brains and the Environment, Fall 2016
Department of Integrative Biology, University of California, Berkeley, Berkeley, CA
Original syllabus drafting and submission to academic senate, lecturer and field leader. 62 students, Faculty Adviser: Alan Shabel, PhD
Grants and Fellowships
Gift ($500k), Anonymous donor, 2023
Hearts to Humanity (H2H8) Research Grant, UC Berkeley, 2022
30th Anniversary Tau Leadership Fellowship, Rainwater Charitable Foundation, 2022
NIH Biology and Biotechnology of Cell and Gene Therapy Training Program (T32GM139780), UC Berkeley Stem Cell Center, 2021-2022
Graduate Research Fellow, Greater Good Science Center, 2021-2022
Graduate Research Allocation Committee Research Grant, UC Berkeley Dept. of Integrative Biology, 2019-2020
Student Volunteer Travel Grant, Alzheimer’s Association, Alzheimer’s Association International Conference, Toronto, Canada, 2016
Honors and Distinctions
30th Anniversary Tau Leadership Award, Rainwater Charitable Foundation, 2022
Reserve & Resilience Workshop Travel Scholarship, Collaboratory on Research Definitions for Reserve and Resilience, 2021
Outstanding Graduate Student Instructor Award, University of California, Berkeley, 2021
Undergraduate Commencement Speaker, Spring 2017 Department Graduation, Dept. of Integrative Biology, University of California, Berkeley, 2017
Student Volunteer Travel Grant, Alzheimer’s Association, Alzheimer’s Association International Conference, Toronto, Canada, 2016
Young Scientist Award for Excellence in Alzheimer’s Research, Honorable Mention, Alzheimer’s Association, Northern California and Northern Nevada Division, 2016
Leaders and Achievers Undergraduate Scholarship, Comcast Corporation, 2013
Professional/Service Activities
Vice Chair, Neuromodulatory Subcortical Systems Professional Interest Area, International Society to Advance Alzheimer’s Research and Treatment, 2022-2024
Student Chair, Neuromodulatory Subcortical Systems Professional Interest Area, International Society to Advance Alzheimer’s Research and Treatment, 2020-2022
Member, General Biology (Bio 1B) Sub-Committee, Curriculum Committee, UC Berkeley Dept. of Integrative Biology, 2020-2021
Abstract Reviewer, Alzheimer’s Association Neuroscience Next Conference, 2020-2020
Abstract Reviewer, Alzheimer’s Association International Conference, 2020-2022
Science Editor, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2019-2022
Member, Development Committee, UC Berkeley Dept. of Integrative Biology, 2019-2021
Journal Reviewer (Alzheimer’s and Dementia, Journal of Alzheimer’s Disease, Plos One, BMC Geriatrics), 2018-Present
Bay Area Science Festival exhibition coordinator, UCSF Weill Institute for Neurosciences, 2018-2019
Bay Area Science Festival exhibition coordinator, UCSF Memory and Aging Center, 2014-2018
Health Sciences Mentor, Early Academic Outreach Program, University of California, San Francisco, 2016
Content Author, National Center for Science Education, 2014
Collaborating Author, 2014 National Climate Assessment Supporting Educational Resources, NOAA, United States Department of Commerce, 2014
Presentations
Conference and symposium lectures
“Pathways underlying selective vulnerability in the early pathogenic stages of Alzheimer’s disease”, AD/PD, 2023, Gothenburg, Sweeden.
“The Lonafarnib target, Rhes, is uniquely dysregulated in tauopathies: A human postmortem study”, Alzheimer’s Association International Conference, 2021, Denver, CO.
“A Locus for studying early vulnerability and behavioral changes in Alzheimer’s disease”, Locus Coeruleus Imaging Meeting, December 2019, Magdeburg, Germany.
“A Locus for Understanding Vulnerability and Resilience in Aging”, Invited Presentation, Hillblom Aging Symposium, November 2019, San Francisco, CA.
“Association of neuropsychiatric symptoms with post-mortem AD pathology”, Oral Presentation, Subjective Cognitive Decline Professional Interest Area (PIA) Session, Alzheimer’s Association International Conference, July 2018, Chicago, IL.
seminars
“Contribution of subcortical system dysfunction to neuropsychiatric symptoms in prodromal Alzheimer’s disease”, Panelist, 2022, Alzheimer’s Association International Society to Advance Alzheimer's Research and Treatment.
“How UC Berkeley’s Innovative Genomics Institute Accelerates COVID-19 Testing to Strengthen Communities”, 2020, Salesforce Webinars.
“Neuroéthologie et maladie (tr. Neuroethology and disease)”, 2018, Université Baptiste au Congo, Kikongo, Democratic Republic of the Congo.
“Tau Modifications in AD: Shifting Focus to Acetylation”, Works in Progress Conference, Memory and Aging Center Tuesday Lecture, Memory and Aging Center, April 2018. University of California, San Francisco.
“Metapresentation: Using posters to leverage your ideas”, UCSF Library’s Presenting your research bootcamp, invited lecture, October 2017. University of California, San Francisco.
“Post-translational modifications of tau in Alzheimer’s disease”, Behavioral Neurology Works in Progress Lecture, Memory and Aging Center, October 2017. University of California, San Francisco.
university course guest lectures
“Neuroethological approaches to dementia”, Guest Lecture, MCB 198: Neuroscience 101, October 2019. University of California, Berkeley.
“Neuroethological approaches to neurodegenerative diseases”, Guest Lecture, IB 198: Neurozoology, September 2019. University of California, Berkeley.
“Alzheimer’s disease: A Neuroethological Perspective”, Guest Lecture, IB 198: Neurozoology, April 2019. University of California, Berkeley.
“Alzheimer’s disease: A Neuroethological Perspective”, Guest Lecture, IB 198: Neurozoology, October 2018. University of California, Berkeley.
“Comparative neuroscience in mammals: Post-mortem studies”, Guest Lecture, BIOE 124: Mammalogy, November 2017. University of California, Santa Cruz.
“Post-mortem approaches to understand structure and function”, Guest Lecture, IB 198: Neurozoology, October 2017. University of California, Berkeley.
“Comparative neuroscience in mammals: Lessons from histology”, Guest Lecture, BIOE 124: Mammalogy, November 2016. University of California, Santa Cruz.
Poster presentations
“Post-Translational Modifications of Tau in Alzheimer's Disease: A Postmortem Study in Humans”, Alzheimer’s Association International Conference, 2018, Chicago, IL.
“Acetylated Tau Distribution in the Human Hippocampus”, Alzheimer’s Association International Conference, 2018, Chicago, IL.
“Alzheimer’s Beyond Dementia: The Contribution of Hyperphosphorylated-Tau Pathology to Neuropsychiatric Symptoms in Alzheimer’s Disease”, Alzheimer's Researchers' Symposium, 2017, University of California, San Francisco.
“Alzheimer’s Beyond Dementia: The Contribution of Hyperphosphorylated-Tau Pathology to Neuropsychiatric Symptoms in Alzheimer’s Disease”, Alzheimer’s Association International Conference, 2017, London, England.
“A Quantitative Investigation of the Locus Coeruleus (LC) in Early Alzheimer's Disease Stages: A Possible Substrate for Prodromal Neuropsychiatric Disorders”, Alzheimer’s Association International Conference, 2016, Toronto, Canada.
“A Quantitative Investigation of the Locus Coeruleus (LC) in Early Alzheimer's Disease Stages: A Possible Substrate for Prodromal Neuropsychiatric Disorders”, Alzheimer's Researchers' Symposium, 2016, University of California, Davis.